These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3286879)

  • 21. Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).
    Fresneau B; Hackshaw A; Hawkins DS; Paulussen M; Anderson JR; Judson I; Litière S; Dirksen U; Lewis I; van den Berg H; Gaspar N; Gelderblom H; Whelan J; Boddy AV; Wheatley K; Pignon JP; De Vathaire F; Le Deley MC; Le Teuff G
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
    Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
    Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palifosfamide, a bifunctional alkylator for the treatment of sarcomas.
    Jung S; Kasper B
    IDrugs; 2010 Jan; 13(1):38-48. PubMed ID: 20024846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
    García Del Muro X; Maurel J; Martínez Trufero J; Lavernia J; López Pousa A; de Las Peñas R; Cubedo R; Berros JP; Casado Herráez A; de Juan A; Martín Broto J
    Invest New Drugs; 2018 Jun; 36(3):468-475. PubMed ID: 29527631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case.
    Sueta A; Yamamoto Y; Inoue K; Kuriwaki K; Iwase H
    Surg Today; 2011 Aug; 41(8):1145-9. PubMed ID: 21773909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma].
    Chen LK; Xu GC; Teng XY; Liang Y; Liu JL; Zhou XM
    Ai Zheng; 2002 Aug; 21(8):903-6. PubMed ID: 12478904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials with ifosfamide: the Indiana University experience.
    Loehrer PJ; Williams SD; Nichols CR; Einhorn LH
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):35-9. PubMed ID: 1329210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ifosfamide and mesna in epithelial ovarian carcinoma.
    Sutton G
    Gynecol Oncol; 1993 Oct; 51(1):104-8. PubMed ID: 8244163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of ifosfamide in the polychemotherapy of metastasized testicular cancer pretreated with chemotherapy.
    Clemm C; Hartenstein R; Wilmanns W
    Arzneimittelforschung; 1982; 32(12):1557-60. PubMed ID: 6891596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ifosfamide in non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
    Gandola L; Pozzi E; Tansini G
    G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
    [No Abstract]   [Full Text] [Related]  

  • 33. Ifosfamide: chemotherapy with new promise and new problems for the urologist.
    Watson RA
    Urology; 1984 Nov; 24(5):465-8. PubMed ID: 6495457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.
    Fields KK; Elfenbein GJ; Lazarus HM; Cooper BW; Perkins JB; Creger RJ; Ballester OF; Hiemenz JH; Janssen WE; Zorsky PE
    J Clin Oncol; 1995 Feb; 13(2):323-32. PubMed ID: 7844593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of ifosfamide in one-agent chemotherapy of malignant testicular tumors].
    Madej G; Porwit-Ksiazek A; Siedlecki P; Zborzil J
    Pol Tyg Lek; 1982 Jul; 37(24-25):717-9. PubMed ID: 6294642
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of ifosfamide in the treatment of sarcomas.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 39. Ifosfamide and mesna.
    Schoenike SE; Dana WJ
    Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences with holoxan within the framework of sequential combination therapy (author's transl)].
    Hartwich G; Neidhardt B; Lutz H
    Med Klin; 1978 Sep; 73(36):1247-52. PubMed ID: 692477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.